KBT Medipharma Private Limited
About KBT Medipharma Private Limited
Data last updated:
KBT Medipharma Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 20 September 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U74999UP2017PTC097143. Its GSTIN is 09AAGCK7732C1ZJ (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Satender and Vidyanand Chandrakant Ojha.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Lucknow, Uttar Pradesh.
As per the financials filed for FY 2022, the company reported a revenue of ₹1.84 Lakh, a decline of 17% compared to the previous year. For the same year it recorded a net loss of ₹6,770 (net margin -3.7%) and EBITDA of ₹15,040 (EBITDA margin 8.2%). Revenue has declined at a compounded annual rate (CAGR) of 17% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
KBT Medipharma Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressTc – V – 13 – 2/A, Vibhuti Khand, Lucknow, Uttar Pradesh, India – 226010
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
To see the full contact details of KBT Medipharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of KBT Medipharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of KBT Medipharma Private Limited, buy the company report.
Financials of KBT Medipharma Private Limited
FY 2022 filings availableKBT Medipharma Private Limited reported revenue of ₹1.84 Lakh (down 17% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 17% over three years, including a 17% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹15,040 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹6,770 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.2% | ||||
| Net Profit Margin | -3.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of KBT Medipharma Private Limited, buy the company report.
Board of directors of KBT Medipharma Private Limited
KBT Medipharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satender | Director | 27 Dec 2022 | 3 Years 10 Months | Current |
| Vidyanand Chandrakant Ojha | Director | 27 Dec 2022 | 3 Years 10 Months | Current |
Peer comparison
KBT Medipharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ayudhi Life Science Private Limited | ₹1.85 Lakh (FY 2022) | Bangalore, Karnataka, India | ||||
| Colloids and Coagulants India Private Limited | ₹1.85 Lakh (FY 2025) | -71.0% | Coimbatore, Tamil Nadu, India | |||
| Azad Marketing and MFGR Pvt Ltd | ₹1.85 Lakh (FY 2025) | -100.0% | Ahmedabad, Gujarat, India | |||
| Noventis International Private Limited | ₹1.85 Lakh (FY 2025) | -78.0% | Ahmedabad, Gujarat, India | |||
| Manasri Medicare (OPC) Private Limited | ₹1.84 Lakh (FY 2025) | -33.0% | Amlaner, Maharashtra, India | |||
| KBT Medipharma Private Limitedthis company | ₹1.84 Lakh (FY 2022) | -₹6,770 | -3.7% | -17.0% | Lucknow, Uttar Pradesh, India | |
| Epo-Chemie Private Ltd | ₹1.84 Lakh (FY 2024) | 24.0% | Thane, Maharashtra, India | |||
| Omnilucid Private Limited | ₹1.82 Lakh (FY 2021) | 85.0% | Faridabad, Haryana, India | |||
| Pepthera Laboratories Private Limited | ₹1.82 Lakh (FY 2025) | -87.0% | Guwahati, Assam, India | |||
| Deoghar Clean Fuel Private Limited | ₹1.82 Lakh (FY 2025) | -22.0% | Sarwan, Jharkhand, India | |||
| Genisis Pharmaceutical (OPC) Private Limited | ₹1.82 Lakh (FY 2020) | -67.0% | Sangamner, Maharashtra, India |
To see the full peer comparison of KBT Medipharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving KBT Medipharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for KBT Medipharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
KBT Medipharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAGCK7732C1ZJ | Uttar Pradesh | Active | 17 Oct 2017 |
To see the full GST registrations and return filing status of KBT Medipharma Private Limited, buy the company report.
Recent activity
KBT Medipharma Private Limited has 4 board changes on record since 2022: 2 appointments and 2 cessations. The latest: Govind Kumar Tiwari ceased to be Director on 27 Dec 2022.
Frequently asked questions
KBT Medipharma is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 20 September 2017 (9+ years old) and is registered under CIN U74999UP2017PTC097143.
KBT Medipharma has 2 current directors:
- Satender - Director
- Vidyanand Chandrakant Ojha - Director
The latest financial statements of KBT Medipharma on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2018 are in the company report.
The GSTIN of KBT Medipharma is 09AAGCK7732C1ZJ, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of KBT Medipharma is U74999UP2017PTC097143. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
KBT Medipharma was incorporated on 20 September 2017, making it 9+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of KBT Medipharma by revenue are Ayudhi Life Science Private Limited, Colloids and Coagulants India Private Limited, Azad Marketing and MFGR Pvt Ltd, Noventis International Private Limited, Manasri Medicare (OPC) Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Govind Kumar Tiwari ceased to be Director on 27 Dec 2022. Rahul Tiwari ceased to be Director on 27 Dec 2022. Satender was appointed as Director on 27 Dec 2022. KBT Medipharma has 4 board changes on record in total.
The registered office of KBT Medipharma is at Tc – V – 13 – 2A, Vibhuti Khand, Lucknow, Uttar Pradesh, India – 226010.
KBT Medipharma operates in the business services industry, in the miscellaneous business activities segment.
The compliance status of KBT Medipharma is compliant as of 17 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
